Serum total homocysteine concentration before and after renal transplantation

Kidney International

Volumn 54, Issue 4, 1998, Pages 1380-1384

  Arnadottir, Margret ^a   Hultberg, Björn ^b   Wahlberg, Jan ^b   Fellström, Bengt ^b   Dimény, Emöke ^b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b NONE

Author keywords

Atherosclerosis; Cyclosporine; End stage renal disease; Endothelial toxicity; Glomerular filtration rate; Homocysteine; Platelets and coagulation

Indexed keywords

ALBUMIN; CREATININE; CYCLOSPORIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLIC ACID BLOOD LEVEL; HEMODIALYSIS; HOMOCYSTINURIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0031660389     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00112.x     Document Type: Article

References (19)

1. STAMPFER MJ, MALINOW MR, WILLETT WC, NEWCOMER LM, UPSON B, ULLMANN D, TISHLER PV, HENNEKENS CH: A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268:877-881, 1992
2. ARNESEN E, REFSUM H, BÖNÅ KH, UELAND PM, FÖRDE OH, NORDREHAUG JE: Serum total homocysteine and coronary heart disease. Int J Epidemiol 24:704-709, 1995
3. UELAND PM, REFSUM H, BRATTSTRÖM L: Plasma homocysteine and cardiovascular disease, in Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function, edited by FRANCIS RB JR. New York, Marcel Dekker, Inc., 1992, pp 183-236
4. BOUSHEY CJ, BERESFORD SAA, OMENN GS, MOTULSKY AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 274:1049-1057, 1995
5. DENNIS VW, ROBINSON K: Homocysteinemia and vascular disease in end stage renal disease. Kidney Int 50(Suppl 57):S11-S17, 1996
6. RAINE AEG, MARGREITER R, BRUNNER FP, EHRICH JHH, GEERLINGS W, LANDAIS P, LOIRAT C, MALLICK NP, SELWOOD NH, TUFVESSON G, VALDERRABANO F: Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant 7(Suppl 2):7-35, 1992
7. ARNADOTTIR M, HULTBERG B, NILSSON-EHLE P, THYSELL H: The effect of reduced glomerular filtration rate on plasma total homocysteine concentration. Scand J Clin Lab Invest 56:41-16, 1996
8. BOSTOM A, BROSNAN JT, HALL B, NADEAU MR, SELHUB J: Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclerosis 116:59-62, 1995
9. WILCKEN DEL, GUPTA VJ, BETTS AK: Homocysteine in the plasma of renal transplant recipients: Effects of cofactors for methionine metabolism. Clin Sci 61:743-749, 1981
10. MASSY ZA, CHADEFAUX-VEKEMANS B, CHEVALIER A, BADER CA, DRUEKE TB, LEGENDRE C, LACOUR B, KAMOUN P, KREIS H: Hyperhomocysteinemia: A significant risk factor for cardiovascular disease in renal transplant recipients. Nephrol Dial Transplant 9:1103-1108, 1994
11. ARNADOTTIR M, HULTBERG B, VLADOV V, NILSSON-EHLE P, THYSELL H: Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients. Transplantation 61:509-512, 1996
12. LINDHOLM A, ALBRECHTSEN D, TUFVESON G, KARLBERG I, PERSSON NH, GROTH CG: A randomized trial of cyclosporine and prednisolone versus cyclosporine, azathioprine and prednisolone in primary cadaveric renal transplantation. Transplantation 54:624-631, 1992
13. ANDERSSON A, ISAKSSON A, BRATTSTRÖM L, HULTBERG H: Determination of homocysteine and other thiols in human plasma by high-performance liquid chromatography and a thiol-specific postcolumn derivatization procedure. Clin Chem 39:1590-1597, 1993
14. NYGARD O, NORDREHAUG JE, REFSUM H, UELAND PM, FARSTAD M, VOLLSET SE: Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337:230-236, 1997
15. FOGARTY DG, WOODSIDE J, LIGHTBODY JH, LOUGHREY CM, YARNELL J, YOUNG IS, MAXWELL AP: Plasma homocysteine in renal transplant recipients. (abstract) J Am Soc Nephrol 7:1931, 1996
16. ARNADOTTIR M, BRATTSTRÖM L, SIMONSEN O, THYSELL H, HULTBERG B, ANDERSSON A, NILSSON-EHLE P: The effect of high dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations. Clin Nephrol 40:236-240, 1993
17. BOSTOM AG, SHEMIN D, LAPANE KL, HUME AL, YOBURN D, NADEAU MR, BENDICH A, SELHUB J, ROSENBERG IH: High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients. Kidney Int 49:147-152, 1996
18. BERGER PB, JONES JD, OLSON LJ, EDWARDS BS, FRANTZ RP, RODEHEFFER RJ, KOTTKE BA, DALY RC, MCGREGOR CGA: Increase in total plasma homocysteine concentration after cardiac transplantation. Mayo Clin Proc 70:125-131, 1995
19. ARNADOTTIR M, HULTBERG B: Treatment with high-dose folic acid effectively lowers plasma homocysteine concentration in cyclosporine-treated renal transplant recipients. (letter) Transplantation 64:1087, 1997